- Home
- SVRA vs NQP Comparison
SVRA vs NQP Comparison
Compare SVRA & NQP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- NQP
- Stock Information
- Founded
- SVRA 2007
- NQP 1990
- Country
- SVRA United States
- NQP United States
- Employees
- SVRA N/A
- NQP N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- NQP Trusts Except Educational Religious and Charitable
- Sector
- SVRA Health Care
- NQP Finance
- Exchange
- SVRA Nasdaq
- NQP Nasdaq
- Market Cap
- SVRA 473.6M
- NQP 413.9M
- IPO Year
- SVRA N/A
- NQP N/A
- Fundamental
- Price
- SVRA $3.04
- NQP $10.87
- Analyst Decision
- SVRA Buy
- NQP
- Analyst Count
- SVRA 7
- NQP 0
- Target Price
- SVRA $5.57
- NQP N/A
- AVG Volume (30 Days)
- SVRA 1.1M
- NQP 58.4K
- Earning Date
- SVRA 08-13-2025
- NQP 01-01-0001
- Dividend Yield
- SVRA N/A
- NQP 3.21%
- EPS Growth
- SVRA N/A
- NQP N/A
- EPS
- SVRA N/A
- NQP N/A
- Revenue
- SVRA N/A
- NQP N/A
- Revenue This Year
- SVRA N/A
- NQP N/A
- Revenue Next Year
- SVRA N/A
- NQP N/A
- P/E Ratio
- SVRA N/A
- NQP N/A
- Revenue Growth
- SVRA N/A
- NQP N/A
- 52 Week Low
- SVRA $1.89
- NQP $9.65
- 52 Week High
- SVRA $4.70
- NQP $11.89
- Technical
- Relative Strength Index (RSI)
- SVRA 69.39
- NQP 41.89
- Support Level
- SVRA $2.43
- NQP $10.97
- Resistance Level
- SVRA $2.77
- NQP $11.03
- Average True Range (ATR)
- SVRA 0.20
- NQP 0.07
- MACD
- SVRA 0.04
- NQP 0.01
- Stochastic Oscillator
- SVRA 71.76
- NQP 33.33
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.